Vor Biopharma Inc.
VOR
$0.572
$0.02835.21%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -16.95% | 16.97% | 7.14% | -8.34% | -9.83% |
| Total Depreciation and Amortization | -3.03% | -4.70% | -0.11% | 12.66% | 41.14% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 39.87% | 12.49% | -10.93% | -12.21% | -56.08% |
| Change in Net Operating Assets | 461.49% | -107.81% | 68.02% | -508.57% | -871.29% |
| Cash from Operations | -0.15% | 16.54% | 9.35% | -25.54% | -30.96% |
| Capital Expenditure | 35.14% | 92.69% | 97.74% | -21.28% | 65.42% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -100.00% | -100.00% | 277.54% | 568.80% | 110.80% |
| Cash from Investing | -100.70% | -100.08% | 288.52% | 576.72% | 110.65% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 118,285.11% | -71.97% | -97.38% | -92.35% | -99.96% |
| Repurchase of Common Stock | -36.36% | 68.18% | 90.64% | 54.50% | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 213,044.00% | -76.70% | -114.22% | -96.19% | -99.98% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 313.31% | -281.66% | 403.74% | 189.20% | -337.87% |
